Dasiglucagon acetate

• CAT Number: I042375
• Purity: ≥95%

Dasiglucagon acetate (Cat No.: I042375) is a stable, glucagon analog used for the treatment of severe hypoglycemia, particularly in diabetic patients. It mimics endogenous glucagon by stimulating hepatic glucose release through glycogenolysis and gluconeogenesis. Unlike native glucagon, dasiglucagon is chemically modified for enhanced solubility and stability, allowing for ready-to-use formulations. Administered via injection, it rapidly increases blood glucose levels. Dasiglucagon acetate is also explored in clinical studies for congenital hyperinsulinism and other glucose regulation disorders, offering a reliable alternative to traditional glucagon therapies.